Obesity decreases B cell responses in young and elderly individuals

Obesity

Volumn 24, Issue 3, 2016, Pages 615-625

  Frasca, Daniela ^a   Ferracci, Franco ^a   Diaz, Alain ^a   Romero, Maria ^a   Lechner, Suzanne ^a   Blomberg, Bonnie B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTIDINE DEAMINASE; E47 PROTEIN; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 6; LEPTIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLUENZA; LEAN BODY WEIGHT; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MIDDLE AGED; OBESITY; PRE B LYMPHOCYTE; PROTEIN PHOSPHORYLATION; YOUNG ADULT; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLUENZA, HUMAN; LYMPHOCYTE ACTIVATION;

AGE FACTORS; AGED; B-LYMPHOCYTES; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA VACCINES; INFLUENZA, HUMAN; LYMPHOCYTE ACTIVATION; MALE; OBESITY; YOUNG ADULT;

EID: 84959456985     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21383     Document Type: Article

References (37)

1. Nishimura S, Manabe I, Nagasaki M, et al., CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-920.
2. Lumeng CN, Bodzin JL, Saltiel AR., Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184.
3. Winer DA, Winer S, Shen L, et al., B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011; 17: 610-617.
4. Nikolajczyk BS., B cells as under-appreciated mediators of non-auto-immune inflammatory disease. Cytokine 2010; 50: 234-242.
5. DeFuria J, Belkina AC, Jagannathan-Bogdan M, et al., B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA 2013; 110: 5133-5138.
6. Blomberg BB, Frasca D., Age effects on mouse and human B cells. Immunol Res 2013; 57: 354-360.
7. Frasca D, Blomberg BB., B cell function and influenza vaccine responses in healthy aging and disease. Curr Opin Immunol 2014; 29: 112-118.
8. Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB., High TNF-alpha levels in resting B cells negatively correlate with their response. Exp Gerontol 2014; 54: 116-122.
9. Buffa S, Pellicano M, Bulati M, et al., A novel B cell population revealed by a CD38/CD24 gating strategy: CD38(-)CD24 (-) B cells in centenarian offspring and elderly people. Age 2013; 35: 2009-2024.
10. Duggal NA, Upton J, Phillips AC, Sapey E, Lord JM., An age-related numerical and functional deficit in CD19(+) CD24(hi) CD38(hi) B cells is associated with an increase in systemic autoimmunity. Aging Cell 2013; 12: 873-881.
11. Frasca D, Diaz A, Romero M, et al., Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 2010; 28: 8077-8084.
12. Frasca D, Diaz A, Romero M, et al., Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine 2013; 31: 3603-3610.
13. Frasca D, Diaz A, Romero M, et al., Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine. Int Immunol 2012; 24: 175-182.
14. Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB., Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine 2015; 33: 1433-1439.
15. Bouaziz JD, Calbo S, Maho-Vaillant M, et al., IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 2010; 40: 2686-2691.
16. Goebel P, Janney N, Valenzuela JR, Romanow WJ, Murre C, Feeney AJ., Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J Exp Med 2001; 194: 645-656.
17. Quong MW, Harris DP, Swain SL, Murre C., E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J 1999; 18: 6307-6318.
18. Quong MW, Romanow WJ, Murre C., E protein function in lymphocyte development. Annu Rev Immunol 2002; 20: 301-322.
19. Sayegh CE, Quong MW, Agata Y, Murre C., Eproteins directly regulate expression of activation-induced deaminase in mature B cells. Nat Immunol 2003; 4: 586-593.
20. Schlissel M, Voronova A, Baltimore D., Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev 1991; 5: 1367-1376.
21. Senn JJ., Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J Biol Chem 2006; 281: 26865-26875.
22. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS., TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
23. Bowie A, O'Neill LA., The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 2000; 67: 508-514.
24. Nikolajczyk BS, Jagannathan-Bogdan M, Shin H, Gyurko R., State of the union between metabolism and the immune system in type 2 diabetes. Genes and Immunity 2011; 12: 239-250.
25. Frasca D, Diaz A, Romero M, Ferracci F, Blomberg BB., Micro-RNAs miR-155 and miR-16 decrease AID and E47 in B cells from elderly individuals. J Immunol 2015; 195: 2134-2140.
26. La Cava A, Matarese G., The weight of leptin in immunity. Nat Rev Immunol 2004; 4: 371-379.
27. Wang H, Lafdil F, Kong X, Gao B., Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci 2011; 7: 536-550.
28. Ruderman NB, Carling D, Prentki M, Cacicedo JM., AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest 2013; 123: 2764-2772.
29. Coughlan KA, Valentine RJ, Ruderman NB, Saha AK., AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab Syndr Obes 2014; 7: 241-253.
30. Frasca D, Romero M, Landin AM, Diaz A, Riley RL, Blomberg BB., Protein phosphatase 2A (PP2A) is increased in old murine B cells and mediates p38 MAPK/tristetraprolin dephosphorylation and E47 mRNA instability. Mech Ageing Dev 2010; 131: 306-314.
31. Alemayehu B, Buysman E, Parry D, Becker L, Nathan F., Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population. J Med Econ 2010; 13: 351-361.
32. Zhou Y, Cowling BJ, Wu P, et al., Adiposity and influenza-associated respiratory mortality: a cohort study. Clin Infect Dis 2015; 60: e49-e57.
33. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM., Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985; 254: 3187-3189.
34. Sheridan PA, Paich HA, Handy J, et al., Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes 2012; 36: 1072-1077.
35. Anaya DA, Dellinger EP., The obese surgical patient: a susceptible host for infection. Surg Infect 2006; 7: 473-480.
36. Choban PS, Flancbaum L., The impact of obesity on surgical outcomes: a review. J Am Coll Surg 1997; 185: 593-603.
37. Parmigiani A, Alcaide ML, Freguja R, et al., Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation. PLoS One 2013; 8: e79816.